Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Nature Immunology | Severity of Restrictive Lung Disease after SARS-CoV-2 Infection Is Associated with Distinct Type 1 Immune Networks
2026-04-02
【Frontier Express】Annals of Oncology | Study on the Biological Characteristics and Prognostic Value of Residual Disease Following Neoadjuvant Therapy in HER2+ Early Breast Cancer
2026-04-02
【Frontier Express】Annals of Oncology | Final Analysis of the Phase 3 JAVELIN Renal 101 Trial of Avelumab Plus Axitinib Versus Sunitinib as First-Line Therapy in Advanced Renal Cell Carcinoma
2026-04-02
【Frontier Express】Science Translational Medicine | Enhanced SARS-CoV-2-Specific T Cell Responses in Individuals with B Cell Deficiency Reduce the Risk of Severe COVID-19
2026-04-01
【Frontier Express】Journal of the American Chemical Society | Development of Prostate-Specific Lysosome-Targeting Degraders
2026-04-01
【Frontier Express】Nature Communications | 3D Pentaculture Model Reveals Tumor Cell-Driven Macrophage Polarization in High-Grade Serous Ovarian Cancer
2026-04-01
【Frontier Express】Nature Communications | A Phase II Window-of-Opportunity Study of T-VEC Combined with Atezolizumab in HER2-Negative Breast Cancer
2026-04-01






